Auto-generated event page
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% Yahoo Finance
Score 41
low confidence
1 source posts
Updated Feb 26, 2026, 10:51 PM UTC